Phathom Pharmaceuticals Announces Submission of Six-Month Stability Data in Support of Erosive GERD New Drug Application for Vonoprazan
Six-month stability data remain more than 10x below the acceptable intake limit set by the U.S. Food and Drug Administration (FDA) and continue to support the requested product shelf life
Submission of six-month stability data satisfies Phathom ' s...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news